EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of PPA1 inhibitor candidates for potential repurposing in cancer medicine

Muratcan Menteş, Cihangir Yandım iD

Journal of Cellular Biochemistry · 2023

DOI: 10.1002/jcb.30475 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular Biochemistry, 2023. Verfasst von Muratcan Menteş und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics and Bioengineering, Faculty of Engineering, İzmir University of Economics, Balçova, İzmir, Turkey. Hauptthemen laut MEDLINE: Drug Repositioning, Enzyme Inhibitors, Neoplasms, Pyrophosphatases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inorganic pyrophosphatase 1 (PPA1) is pivotal to cellular metabolism as it facilitates the hydrolysis of PPi—a by‐product of various metabolic processes that influence cell growth and differentiation. Overexpression of PPA1 enzyme has been linked to diminished patient survival and was shown to influence tumor cell dynamics, thereby positioning it as a potential therapy target for a variety of cancers including colorectal cancer, diffuse large B‐cell lymphoma, and lung adenocarcinoma. Despite this therapeutic promise, there are no known inhibitors of PPA1 as of today. In this study, we searched for potential PPA1 inhibitors using a molecular docking screen of 30 470 compounds with a history of clinical trials and/or US Food and Drug Administration approval. We specifically targeted the active pocket that coincides with the established catalytic domain. Our screen identified promising hits, which we further subjected to ADMET (absorption, distribution, metabolism, excretion, and toxicity) filtering. Subsequent molecular dynamics (MD) analyses were conducted on devazepide, quinotolast, and tarazepide—the three substances that successfully navigated all filters. MD analyses reinforced the stability of the protein‐ligand complexes and confirmed ligand binding, as substantiated by our root mean square deviation, radius of gyration and secondary structures of proteins analyses. Furthermore, Molecular Mechanics Poisson‐Boltzmann Surface Area calculations post‐MD identified devazepide and quinotolast as showing higher binding affinities; being supported by principal component analysis, free energy landscape, and dynamic cross‐correlation matrix results. Overall, our study reveals devazepide and quinotolast as potential candidates for PPA1 inhibition which could be considered for repurposing studies that need further experimental validation. These results not only reveal a potential for clinical repurposing for PPA1 inhibition but they also offer valuable insights into the development of future compounds for targeting the crucial PPA1 enzyme.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug RepositioningEnzyme InhibitorsNeoplasmsPyrophosphatasesHumansMolecular Docking SimulationMolecular Dynamics Simulation

Stichwörter der Autor:innen

PPA1cancerdrug screeninhibitormolecular dockingmolecular dynamicsphosphate metabolismrepurposing

Substanzen

Enzyme InhibitorsPyrophosphatases

Autor:innen und Institutionen

  • Department of Genetics and Bioengineering, Faculty of Engineering, İzmir University of Economics, Balçova, İzmir, Turkey.
  • İzmir Biomedicine and Genome Center (IBG), Dokuz Eylül University Health Campus, İnciraltı, İzmir, Turkey.

ORCID-Profile: Cihangir Yandım

Zitieren

APA

Menteş, M., & Yandım, C. (2023). Identification of PPA1 inhibitor candidates for potential repurposing in cancer medicine. Journal of Cellular Biochemistry. https://doi.org/10.1002/jcb.30475

Vancouver

Menteş M, Yandım C. Identification of PPA1 inhibitor candidates for potential repurposing in cancer medicine. Journal of Cellular Biochemistry. 2023. doi:10.1002/jcb.30475

BibTeX
@article{Mente2023,
  author = {Menteş, Muratcan and Yandım, Cihangir},
  title = {Identification of PPA1 inhibitor candidates for potential repurposing in cancer medicine},
  journal = {Journal of Cellular Biochemistry},
  year = {2023},
  doi = {10.1002/jcb.30475}
}
Kostenlos starten →